Health Care/Hospital
Antengene and Its Partners Publish Preclinical Data Demonstrating the Encouraging Activity of Selinexor in the Prevention and Treatment of SARS-CoV-2 Infections
SHANGHAI and HONG KONG, July 26, 2021 /PRNewswire/ -- In June 2021, results from a preclinical study jointly conducted by Antengene, American biopharmaceutical company Karyopharm Therapeutics andUniversity of Georgia College of Veterinary Medicine has been published in a paper titled "selinexor, ...
2021-07-26 08:44
3812
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI321 (Anti-PD-1/TIGIT Bispecific Antibody) in Patients with Advanced Malignant Tumors
SAN FRANCISCO and SUZHOU, China, July 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-07-26 08:00
7692
Suvoda wraps up first half of 2021 with strong business growth, geographical expansion, and new product enhancements
Clinical trial software innovator reports record quarter for business bookings in Q2 CONSHOHOCKEN, Pa., July 26, 2021 /PRNewswire/ -- Suvoda LLC, an innovator in clinical trial software, today announced that it saw significant business growth in the first half of 2021 with some of the major phar...
2021-07-26 08:00
2154
ZumVet launches first virtual veterinary platform in Hong Kong
HONG KONG, July 26, 2021 /PRNewswire/ -- Singapore-based pet telehealth startup ZumVet today announced the launch of its platform inHong Kong, a remote care solution offering a full suite of home-based health and wellness services for pets. This is the first pet-centric app of its kind inHong ...
2021-07-26 06:00
4207
The Global Self-Care Federation Highlights the Need to Take Action on Self-Care to Create Better Health Outcomes for All
GENÈVE, Switzerland, July 23, 2021 /PRNewswire/ -- On the occasion of International Self-Care Day 2021 and WHO Self-Care month, The Global Self-Care Federation (GSCF) underscores the importance of acting on self-care by engaging in positive and consistent self-care practices. Self-care produces o...
2021-07-23 21:41
3409
GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices
ATLANTA, July 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron® brachytherapy afterloader systems, including service agreements. The cancer treatment devices will allow GenesisCare to contin...
2021-07-23 21:02
9439
The Westin Surabaya Distributes Garden-to-Table Meals for Frontliners and COVID-19 Patients
SURABAYA, Indonesia, July 23, 2021 /PRNewswire/ -- The team at the 5-stars, The
Westin Surabaya
2021-07-23 19:20
3161
Sinopec Builds World's Largest Disinfectant Production Base
QIANJIANG, China, July 23, 2021 /PRNewswire/ -- Sinopec Jianghan Salt Chemical Hubei Co., Ltd. (the "Company"), a subsidiary of China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec"), has completed a trial run of its new 12,000 tons/year concentrated bleaching powder batch feeder onJuly 23...
2021-07-23 18:36
10347
Norgine B.V. and US WorldMeds enter into exclusive licensing agreement to commercialise DFMO (eflornithine) in Europe, Commonwealth of Independent States, Australia and New Zealand
AMSTERDAM, Netherlands and LOUISVILLE, Ky., July 23, 2021 /PRNewswire/ -- NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and US WorldMeds (USWM), aKentucky-based specialty pharmaceutical company, today announced an exclusive licensing agreement by which Norgine will r...
2021-07-23 16:00
2266
Data from 14 leading cancer centers presented at AAPM highlight global adoption of Elekta Unity MR-Linac
Presentation of 36 abstracts underscore the potential of Elekta Unity to advance precision radiation medicine ATLANTA, July 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced the presentation of 36 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Uni...
2021-07-23 14:17
8565
Texas Cardiac Arrhythmia Institute leader participates in clinical trial for world's first artificial intelligence technology for complex cardiac arrhythmia procedures
AUSTIN, Texas, July 23, 2021 /PRNewswire/ -- The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently led a clinical study to evaluate the world's first data-driven artificial intelligence (AI) platform for cardiac electrophysiology (EP) procedures.Andrea...
2021-07-23 03:26
4202
FDA Provides Necessary Guidance For BioVaxys To Begin Preparation Of Ind For Phase I/II Clinical Trials Of CoviDTH
VANCOUVER, British Columbia, July 22, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTCQB: BVAXF)("BioVaxys"), is pleased to announce today that the US Food and Drug Administration ("FDA") has provided its official Written Response to the Company's request for a Pre-IN...
2021-07-22 21:50
10533
Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack, Latest Addition to Ortho's Critical Care Blood Testing Menu
RARITAN, N.J., July 22, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its VITROS® Immunodiagnostic Products IL-6 Reagent Pack, the latest addition to Ortho's VITROS® Critical Care menu, is now ...
2021-07-22 21:00
8236
Mentice publishes the company's interim report for the period January-June 2021
- Mentice delivers record level of sales for the second quarter and first half year STOCKHOLM, July 22, 2021 /PRNewswire/ -- Second quarter (April–June 2021) and first half year (January-June 2021) * Order intake amounted to 40.2 (28.4) MSEK for the second quarter and 80.1 (60.9) MSEK for th...
2021-07-22 15:25
2034
Intas Enters into an Exclusive License Agreement with Meiji and Dong-A ST to commercialize DMB-3115 (Proposed Biosimilar to Ustekinumab)
Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high quality medicines by entering into an exclusive license agreement AHMEDABAD, India, July 22, 2021 /PRNewswire/ -- Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high...
2021-07-22 13:00
4168
Amadeus Integrates IBM Digital Health Pass Into Its Digital Health Verification Technology
Integration is designed to help streamline the validation of air travelers' COVID-19 health documentation, reducing friction during check-in, and supporting airlines as the industry works to increase international travel volumes ARMONK, N.Y. and MADRID, July 22, 2021 /PRNewswire/ -- IBM (NYSE: IB...
2021-07-22 12:00
9849
Menarini Asia-Pacific strengthens Men's Health portfolio in China with acquisition of Cialis(R) (Tadalafil) from Lilly
* Acquisition of Cialis® in the People's Republic of China to bolster Menarini's Men's Health portfolio and drive multichannel coverage * This is a significant milestone for Menarini Asia operations as it commemorates its 10th anniversary of being established in 13 major healthcare markets in...
2021-07-22 10:00
4659
Antengene Announces The Approval by Human Research Ethics Committee in Australia and to Start the Phase 1 Trial of ATG-101 (the first PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma
SHANGHAI and HONG KONG, July 22, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...
2021-07-22 09:27
3410
Joysbio's COVID-19 RAPID tests detect NEW SARS-COV-2 variants
TIANJIN, China, July 22, 2021 /PRNewswire/ -- Joysbio, one of the world's leading manufacturers of lateral flow rapid test kits, has proven that their SARS-CoV-2 (COVID-19) antigen tests can detect new variants, including the Delta variant that's sweeping the world. With over 100 million tests so...
2021-07-22 08:37
3792
China NMPA Approves Phase III Clinical Trial of ASC40 Combined with Bevacizumab for Treatment of Patients with Recurrent Glioblastoma
HANGZHOU, China and SHAOXING, China, July 22, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Phase III clinical trial application of ASC40 combined with Bevacizumab for treatment of patients w...
2021-07-22 08:30
3953
Week's Top Stories
Most Reposted
DayOne Secures Over 1GW Renewable Energy in Malaysia in Landmark TNB Partnership
[Picked up by 303 media titles]
2026-06-04 23:55
Amartha Initiates Coalition to Advance Financial Health for Grassroots Communities in Indonesia
[Picked up by 296 media titles]
2026-06-05 19:08
DayOne Data Centers Announces Final Closing of its Series C Equity Financing at US$4.5 Billion
[Picked up by 294 media titles]
2026-06-05 15:00FPT and NVIDIA Collaborate to Release the Nemotron Personas Vietnam Datasets
[Picked up by 280 media titles]
2026-06-05 17:34
Pudu Robotics and Shenzhen CTID Co. Ltd Launch the World's First Full-Scenario Robot-Serviced Hotel Project
[Picked up by 275 media titles]
2026-06-01 18:00Most Read
WePlay Korea's 4th Anniversary Celebration Kicks Off, Joining Hands with "Hello Panda-哈啰潘达" to Create Fu Bao Themed Space Decorations
2026-06-01 12:00
8425
YY Group (NASDAQ: YYGH) Wins Prestigious HAPA Solutions Excellence Award, Validating Enterprise AI Marketplace Adoption in Southeast Asia
2026-06-05 19:37
8033
Dreame ranked No.1 in Global Robot Vacuum Sales & Revenue, according to International Data Corporation (IDC)
2026-06-05 21:05
7927
